Earnings History Data for Protalix BioTherapeutics, Inc. (PLX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of recombinant therapeutic proteins. The company's product pipeline includes ProCellEx(R). Protalix BioTherapeutics Inc. is based in CARMIEL, Israel.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
14-03-2024 PM PLX Protalix BioTherapeutics, Inc. 104.32 -0.07 -0.03 -0.07 Protalix BioTherapeutics GAAP EPS of $0.09 misses by $0.01, revenue of $65.49M beats by $1.54M
[3/14/2024 6:51 AM]
1.36 -0.16 
(-10.20%)
1.54 0.02 
(1.30%)
1.21 - 3.55 1,167,881 360,000 34,548
06-11-2023 PM PLX Protalix BioTherapeutics, Inc. 120.97 -0.04 -0.07 -0.07 Protalix BioTherapeutics GAAP EPS of -$0.04 beats by $0.03, revenue of $10.35M beats by $2.71M
[11/6/2023 6:53 AM]
1.52 -0.33 
(-17.83%)
1.71 -0.14 
(-7.57%)
1.00 - 3.55 1,445,604 420,000 222,418
07-08-2023 PM PLX Protalix BioTherapeutics, Inc. 112.51 0.21 -0.04 -0.11 Protalix BioTherapeutics beats Q2 top and bottom line estimates
[8/7/2023 6:54 AM]
1.88 0.22 
(12.95%)
1.93 0.27 
(16.27%)
1.00 - 3.55 3,446,343 750,000 1,630,204
04-05-2023 PM 6:50 AM ET
(May 4)
PLX Protalix BioTherapeutics, Inc. 151.49 -0.05 0.00 -0.05 Protalix BioTherapeutics GAAP EPS of -$0.05, revenue of $9.59M
[5/4/2023 6:53 AM]
3.33 0.18 
(5.72%)
3.02 -0.13 
(-4.13%)
0.98 - 3.36 3,207,987 2,300,000 188,740
27-02-2023 PM 6:50 AM ET
(Feb 27)
PLX Protalix BioTherapeutics, Inc. 83.60 -0.07 -0.15 -0.14 Protalix BioTherapeutics GAAP EPS of -$0.22 beats by $0.17, revenue of $62.89M beats by $17.75M
[2/27/2023 6:37 AM]
1.90 0.08 
(4.40%)
1.80 -0.02 
(-1.10%)
0.80 - 2.02 2,072,542 940,000 320,169
14-11-2022 PM 6:50 AM ET
(Nov 14)
PLX Protalix BioTherapeutics, Inc. 51.25 -0.07 -0.15 -0.09 Protalix BioTherapeutics GAAP EPS of -$0.07, revenue of $14.18M
[11/14/2022 6:54 AM]
1.05 0.0 
(0.00%)
1.14 0.09 
(8.57%)
0.70 - 2.00 135,321 80,000 32,656
15-08-2022 PM 6:50 AM ET
(Aug 15)
PLX Protalix BioTherapeutics, Inc. 49.89 -0.11 -0.18 -0.25 Protalix BioTherapeutics GAAP EPS of -$0.11 beats by $0.07, revenue of $8.75M beats by $6.08M
[8/15/2022 6:52 AM]
1.24 0.02 
(1.22%)
1.22 0.0 
(0.00%)
0.70 - 2.00 88,427 190,000 22,431
16-05-2022 PM 6:50 AM ET
(May 16)
PLX Protalix BioTherapeutics, Inc. 47.29 -0.05 0.00 -0.14 Protalix BioTherapeutics GAAP EPS of -$0.05, revenue of $16.09M
[5/16/2022 6:53 AM]
1.08 0.02 
(1.90%)
1.10 0.04 
(3.77%)
0.70 - 3.08 135,082 410,000 10,675
31-03-2022 PM 6:50 AM ET
(Mar 31)
PLX Protalix BioTherapeutics, Inc. 48.75 -0.14 -0.11 0.03 Protalix BioTherapeutics GAAP EPS of -$0.62 misses by $0.03, revenue of $38.35M beats by $0.76M
[3/31/2022 6:52 AM]
1.07 0.02 
(1.90%)
1.06 0.01 
(0.95%)
0.70 - 6.64 1,064,524 330,000 17,646
15-11-2021 PM 6:50 AM ET
(Nov 15)
PLX Protalix BioTherapeutics, Inc. 50.11 -0.09 -0.12 -0.14 1.16 0.02 
(1.75%)
1.14 0.0 
(0.00%)
1.07 - 7.02 6,266,910 580,000 40,776
16-08-2021 PM 6:50 AM ET
(Aug 16)
PLX Protalix BioTherapeutics, Inc. 67.42 -0.25 -0.08 -0.13 Protalix BioTherapeutics EPS misses by $0.17, beats on revenue
[8/16/2021 6:53 AM]
1.33 -0.01 
(-0.75%)
1.36 0.02 
(1.49%)
1.32 - 7.02 665,016 630,000 21,064
14-05-2021 PM 6:50 AM ET
(May 14)
PLX Protalix BioTherapeutics, Inc. 133.43 -0.14 -0.17 0.10 Protalix BioTherapeutics EPS beats by $0.03, beats on revenue
[5/14/2021 6:51 AM]
2.73 -0.14 
(-4.70%)
2.91 0.04 
(1.39%)
2.61 - 7.02 1,488,178 1,500,000 21,625
30-03-2021 PM 6:50 AM ET
(Mar 30)
PLX Protalix BioTherapeutics, Inc. 219.20 0.03 -0.09 0.00 Protalix BioTherapeutics EPS beats by $0.12, beats on revenue
[3/30/2021 7:00 AM]
4.53 -0.17 
(-3.62%)
4.64 -0.06 
(-1.28%)
2.12 - 7.02 519,439 460,000 33,603
29-10-2020 PM 6:50 AM ET
(Oct 29)
PLX Protalix BioTherapeutics, Inc. 117.68 -0.14 -0.08 -0.20 Protalix BioTherapeutics EPS misses by $0.17, beats on revenue
[10/29/2020 6:53 AM]
3.35 -0.20 
(-5.63%)
3.47 -0.08 
(-2.25%)
1.85 - 4.86 312,418 42,422 3,049
10-08-2020 PM 6:50 AM ET
(Aug 10)
PLX Protalix BioTherapeutics, Inc. 117.44 -0.13 -0.20 -0.50 Protalix BioTherapeutics EPS beats by $0.07, beats on revenue
[8/10/2020 6:52 AM]
3.57 -0.02 
(-0.56%)
3.65 0.06 
(1.67%)
1.70 - 4.86 33,402 74,123 3,403
01-06-2020 PM 6:50 AM ET
(Jun 1)
PLX Protalix BioTherapeutics, Inc. 115.17 0.10 -0.30 -0.50 Protalix BioTherapeutics EPS beats by $0.40
[6/1/2020 6:55 AM]
3.41 0.07 
(2.10%)
3.53 0.19 
(5.69%)
1.70 - 5.19 274,188 211,817 72,413